Related Experiment Video
Updated: Aug 31, 2025

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Copper (II) complexes with N, S donor pyrazole-based ligands as anticancer agents
Monireh Ghorbanpour1, Behzad Soltani2, Ali Mota3
1Department of Chemistry, Faculty of Basic Science, Azarbaijan Shahid Madani University, P. O. Box 53714-161, Tabriz, Iran.
New copper complexes with pyrazole ligands show significant anticancer activity against breast cancer cells. These compounds exhibit strong interactions with cancer-related proteins, suggesting potential as novel chemotherapeutic agents.
Area of Science:
- Coordination Chemistry
- Medicinal Chemistry
- Materials Science
Background:
- Pyrazole derivatives are versatile ligands in coordination chemistry.
- Copper complexes have shown promise in anticancer drug development.
- Understanding structure-activity relationships is crucial for designing effective chemotherapeutics.
Purpose of the Study:
- To synthesize and characterize novel pyrazole-based copper(II) complexes.
- To evaluate the in vitro cytotoxic activity of these complexes against human breast carcinoma (MCF-7) cell lines.
- To investigate the molecular interactions and structure-activity relationships of the synthesized compounds.
Main Methods:
- Synthesis and characterization of ligands and copper(II) complexes using spectroscopic and physicochemical methods.
- X-ray crystallography for structural determination of a representative complex.
- Cyclic voltammetry for electrochemical activity assessment.
- MTT assay for in vitro cytotoxicity evaluation.
- Molecular docking studies against EGFR and CDK2 proteins.
- Quantitative Structure-Activity Relationship (QSAR) analysis.
Main Results:
- Twenty pyrazole derivative ligands and their copper(II) complexes were successfully synthesized.
- The crystal structure revealed a distorted square planar geometry for a representative copper complex.
- Copper complexes demonstrated significant in vitro cytotoxicity against MCF-7 cells compared to free ligands.
- Docking studies indicated enhanced interactions of copper complexes with EGFR and CDK2 proteins.
- QSAR analysis identified dipole moment as a key factor correlating with anticancer activity.
Conclusions:
- The synthesized copper(II) complexes exhibit potent anticancer activity, warranting further investigation.
- These complexes show promising interactions with key cancer-related proteins.
- The findings suggest that these copper complexes are potential candidates for development as novel chemotherapeutic agents for cancer treatment.
Related Concept Videos
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
Complexation Equilibria: The Chelate Effect
Coordination Number and Geometry
EDTA: Chemistry and Properties
Complexometric Titration: Ligands
Extraction: Advanced Methods

